Pivotal: Staidson and Pivotal Collaborate in Trial of Progressive Severe COVID-19 Patients

Staidson and Pivotal have announced a new strategic collaboration to assess Staidson s investigational product BDB-001 in a Europe-based clinical trial in progressive severe COVID-19 patients caused by SARS-CoV-2. This clinical trial is a multicenter, open-label, randomized and controlled study.